IgM antiphospholipid antibodies are associated with a microvascular phenotype in antiphospholipid syndrome
Abstract Background The clinical significance of IgM antiphospholipid antibodies (aPL) in antiphospholipid syndrome (APS) remains uncertain, while lupus anticoagulant is a well-established marker for thrombotic risk. Methods The objective of the study is to evaluate the impact of IgM aPL on the clin...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2026-06-01
|
| Rangatū: | Advances in Rheumatology |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s42358-026-00553-z |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
